161 related articles for article (PubMed ID: 24837543)
1. A randomized trial of diet in men with early stage prostate cancer on active surveillance: rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]).
Parsons JK; Pierce JP; Mohler J; Paskett E; Jung SH; Humphrey P; Taylor JR; Newman VA; Barbier L; Rock CL; Marshall J
Contemp Clin Trials; 2014 Jul; 38(2):198-203. PubMed ID: 24837543
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial.
Parsons JK; Zahrieh D; Mohler JL; Paskett E; Hansel DE; Kibel AS; Liu H; Seisler DK; Natarajan L; White M; Hahn O; Taylor J; Hartman SJ; Stroup SP; Van Veldhuizen P; Hall L; Small EJ; Morris MJ; Pierce JP; Marshall J
JAMA; 2020 Jan; 323(2):140-148. PubMed ID: 31935026
[TBL] [Abstract][Full Text] [Related]
3. Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.
Parsons JK; Pierce JP; Mohler J; Paskett E; Jung SH; Morris MJ; Small E; Hahn O; Humphrey P; Taylor J; Marshall J
BJU Int; 2018 Apr; 121(4):534-539. PubMed ID: 28437029
[TBL] [Abstract][Full Text] [Related]
4. Dietary modification in patients with prostate cancer on active surveillance: a randomized, multicentre feasibility study.
Parsons JK; Newman VA; Mohler JL; Pierce JP; Flatt S; Marshall J
BJU Int; 2008 May; 101(10):1227-31. PubMed ID: 18218061
[TBL] [Abstract][Full Text] [Related]
5. The Men's Eating and Living (MEAL) study: a Cancer and Leukemia Group B pilot trial of dietary intervention for the treatment of prostate cancer.
Parsons JK; Newman V; Mohler JL; Pierce JP; Paskett E; Marshall J;
Urology; 2008 Sep; 72(3):633-7. PubMed ID: 18280560
[TBL] [Abstract][Full Text] [Related]
6. Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance]).
Kellogg Parsons J; Zahrieh D; Patel D; Mohler JL; Chen RC; Paskett ED; Liu H; Peil ES; Rock CL; Hahn O; Taylor J; Van Veldhuizen PJ; Small EJ; Morris MJ; Naughton MJ; Pierce JP; Marshall J
Eur Urol Focus; 2022 Nov; 8(6):1607-1616. PubMed ID: 35504836
[TBL] [Abstract][Full Text] [Related]
7. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.
Wilt TJ
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771
[TBL] [Abstract][Full Text] [Related]
8. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
9. An evidence review of active surveillance in men with localized prostate cancer.
Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS).
Schenk JM; Neuhouser ML; Beatty SJ; VanDoren M; Lin DW; Porter M; Gore JL; Gulati R; Plymate SR; Wright JL
Contemp Clin Trials; 2019 Jun; 81():34-39. PubMed ID: 31002955
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
[TBL] [Abstract][Full Text] [Related]
12. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
Nair B; Wilt T; MacDonald R; Rutks I
Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial.
Shike M; Latkany L; Riedel E; Fleisher M; Schatzkin A; Lanza E; Corle D; Begg CB
J Clin Oncol; 2002 Sep; 20(17):3592-8. PubMed ID: 12202659
[TBL] [Abstract][Full Text] [Related]
14. PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design.
Ahlberg MS; Adami HO; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jäderling F; Wassberg C; Åberg UWN; Bill-Axelson A
BMJ Open; 2019 Aug; 9(8):e027860. PubMed ID: 31444180
[TBL] [Abstract][Full Text] [Related]
15. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.
Eastham JA; Kelly WK; Grossfeld GD; Small EJ;
Urology; 2003 Dec; 62 Suppl 1():55-62. PubMed ID: 14747042
[TBL] [Abstract][Full Text] [Related]
16. Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer.
Antwi SO; Steck SE; Zhang H; Stumm L; Zhang J; Hurley TG; Hebert JR
Cancer Epidemiol; 2015 Oct; 39(5):752-62. PubMed ID: 26165176
[TBL] [Abstract][Full Text] [Related]
17. Predictors of pathological progression among men with localized prostate cancer undergoing active surveillance: a sub-analysis of the REDEEM study.
Margel D; Nandy I; Wilson TH; Castro R; Fleshner N
J Urol; 2013 Dec; 190(6):2039-45. PubMed ID: 23820059
[TBL] [Abstract][Full Text] [Related]
18. A dietary intervention for recurrent prostate cancer after definitive primary treatment: results of a randomized pilot trial.
Carmody J; Olendzki B; Reed G; Andersen V; Rosenzweig P
Urology; 2008 Dec; 72(6):1324-8. PubMed ID: 18400281
[TBL] [Abstract][Full Text] [Related]
19. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
Cary KC; Cowan JE; Sanford M; Shinohara K; Perez N; Chan JM; Meng MV; Carroll PR
Eur Urol; 2014 Aug; 66(2):337-42. PubMed ID: 24035632
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
